Jorden David Emerson
Nuo Therapeutics, Inc. · CEO/CFO
Jorden David Emerson is listed in public filings as director, officer: CEO/CFO. This Jorden David Emerson insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nuo Therapeutics, Inc. (AURX). Investors use Jorden David Emerson's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.3M2.1M shares | Grant / ExerciseJun 5, 2026 | $14.5K13.2k shares | $1.10 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $4.0M2M shares | Grant / ExerciseJan 1, 2026 | $50.0K25.4k shares | $1.97 | -- | |
| $829k2.1M shares | Grant / ExerciseJan 1, 2026 | $50.0K125k shares | $0.40 | -- | |
| $2.9M1.9M shares | SellNov 28, 2025 | $300.0K200k shares | $1.50 | -- | |
| $830k2.1M shares | Grant / ExerciseAug 1, 2025 | $40.0K100k shares | $0.40 | -- | |
| $3.7M2.1M shares | Grant / ExerciseAug 1, 2025 | $37.1K21.3k shares | $1.74 | -- | |
| $867k2.2M shares | Grant / ExerciseAug 1, 2025 | $37.1K92.7k shares | $0.40 | -- |